Herbas VPB

Print
EN | LT
LT - BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
EN - BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/6886
European patent
(11) Number of the document 2714937
(13) Kind of document T
(96) European patent application number 12793322.4
Date of filing the European patent application 2012-05-31
(97) Date of publication of the European application 2014-04-09
(45) Date of publication and mention of the grant of the patent 2018-11-14
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/040183
Date 2012-05-31
PCT application publication
(87) Number WO 2012/166899
Date 2012-12-06
Priority applications
(30) Number Date Country code
201161493294 P 2011-06-03 US
Inventors
(72)
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
MATSUI, Junji, JP
SIMON, Jason S., US
XU, Lucy, US
Grantee
(73) Eisai R&D Management Co., Ltd., 6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, JP
Title
(54) BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
  BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
Last update date 2021-04-30